Dr Mike Messenger

Profile

As Head of the Leeds Centre for Personalised Medicine and Health, my role invovles matching population health and care needs with excellent science and innovation, as part of the Leeds Academic Health Partnership.  The Partnership identifies, attracts and implements innovation and inward investment that responds to the challenges facing health and care, including reducing health inequalities across the city.  

I am also the Deputy Director of the National Institute for Health Research (NIHR) Leeds MedTech and In-Vitro Diagnostic Co-Operative (MIC), an industry facing collaboration aimed at catalysing evaluations of commercial tests and providing evidence for NHS adoption.  Since 2013 the MIC has evaluated >35 diagnostics, leveraged more than £60M of investment and contributed evidence towards 9 clinical guidelines.  

As a standing member of the National Institute for Health and Care Excellence (NICE) Diagnostics Advisory Committee, I provides advice to NICE on the formulation of guidance on diagnostic technologies and any other matter related to the evaluation of diagnostic technologies. I am also an expert advisor on In Vitro Diagnostics to the European Union, Genomics Canada, CRUK, MRC and industry.

Responsibilities

• Head of Leeds Centre for Personalised Medicine and Health
• Deputy Director NIHR MedTech and In Vitro Diagnostic Co-Operative

Research interests

Selected ongoing research and innovation programmes:  

· NIHR Leeds In Vitro Diagnostic Co-Operative - £1.3M  (NIHR: 01/2018-31/12/22) 

· The Yorkshire Lung Screening Trial and Biomarker Sub-Study - £8M ( Yorkshire Cancer Research: 12/2016-12/2021) 

· CanTest cancer diagnostic testing in primary care: a paradigm shift for cancer diagnosis - £4.8M(CRUK: 11/2016-11/2021) 

· Accelerating development of infection diagnostics for patient management and reduction of antibiotic misuse - £3.8M( MRC:05/2016-05/2021)

· Implementing patient stratification in scleroderma through identification of composite index of disease activity - £725,814 ( NIHR: 10/2014-10/2019)  

· Developing a framework for including and utilising pre-analytical factors within economic evaluations of diagnostic tests - £281,947 (NIHR: 10/2016-10/2019) 

Qualifications

• BsC (Hons) - Biotechnology
• PhD - Biomedical Engineering